Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanli Liu

Showing results (711-720 of 731) with videos related to

Pageof 74
Sort By:
Cellular and Molecular Life Sciences : CMLS|March 13, 2024
Inhibition of EHMT1/2 rescues synaptic damage and motor impairment in a PD mouse modelZhixiong Zhang, Rui Wang, Hui Zhou, et al.
Molecular Cancer Research : MCR|December 22, 2019
Multi-Omics Analysis Identifies MGA as a Negative Regulator of the MYC Pathway in Lung AdenocarcinomaPaula Llabata, Yoichiro Mitsuishi, Peter S Choi, et al.
The British Journal of Ophthalmology|December 25, 2025
Efficacy and safety of anti-VEGF monoclonal antibody 601 for macular oedema in retinal vein occlusion: two phase IIa randomised clinical trialsShuo Zhao, Miaoqin Wu, Jingxiang Zhong, et al.
Frontiers in Immunology|October 14, 2022
CEP192 is a novel prognostic marker and correlates with the immune microenvironment in hepatocellular carcinomaYanli Liu, Wanmei Liang, Yabin Chang, et al.
Nature Communications|December 9, 2021
A predominant enhancer co-amplified with the SOX2 oncogene is necessary and sufficient for its expression in squamous cancerYanli Liu, Zhong Wu, Jin Zhou, et al.
Nature Communications|June 5, 2026
Identification of a mechanism-based binding mode for a histone deacetylase 6 inhibitorDaniel A Rodrigues, Yu Wang, Juana Goulart Stollmaier, et al.
Journal of Medicinal Chemistry|June 2, 2021
Structure-Guided Development of Small-Molecule PRC2 Inhibitors Targeting EZH2-EED InteractionDaohai Du, Dandan Xu, Licheng Zhu, et al.
Nature Communications|September 16, 2022
A small molecule antagonist of SMN disrupts the interaction between SMN and RNAP IIYanli Liu, Aman Iqbal, Weiguo Li, et al.
Journal of Medicinal Chemistry|February 1, 2021
Discovery of Small-Molecule Antagonists of the PWWP Domain of NSD2Renato Ferreira de Freitas, Yanli Liu, Magdalena M Szewczyk, et al.
Clinical and Translational Medicine|May 18, 2026
A multi-centre, prospective trial of a methylation-based liquid biopsy for early detection of liver cancer in high-risk populationsRuohan Zhang, Xinrong Yang, Guangming Li, et al.
Pageof 74

Showing results (711-720 of 731) with videos related to

Sort By:
Pageof 74
Cellular and Molecular Life Sciences : CMLS|March 13, 2024
Inhibition of EHMT1/2 rescues synaptic damage and motor impairment in a PD mouse modelZhixiong Zhang, Rui Wang, Hui Zhou, et al.
Molecular Cancer Research : MCR|December 22, 2019
Multi-Omics Analysis Identifies MGA as a Negative Regulator of the MYC Pathway in Lung AdenocarcinomaPaula Llabata, Yoichiro Mitsuishi, Peter S Choi, et al.
The British Journal of Ophthalmology|December 25, 2025
Efficacy and safety of anti-VEGF monoclonal antibody 601 for macular oedema in retinal vein occlusion: two phase IIa randomised clinical trialsShuo Zhao, Miaoqin Wu, Jingxiang Zhong, et al.
Frontiers in Immunology|October 14, 2022
CEP192 is a novel prognostic marker and correlates with the immune microenvironment in hepatocellular carcinomaYanli Liu, Wanmei Liang, Yabin Chang, et al.
Nature Communications|December 9, 2021
A predominant enhancer co-amplified with the SOX2 oncogene is necessary and sufficient for its expression in squamous cancerYanli Liu, Zhong Wu, Jin Zhou, et al.
Nature Communications|June 5, 2026
Identification of a mechanism-based binding mode for a histone deacetylase 6 inhibitorDaniel A Rodrigues, Yu Wang, Juana Goulart Stollmaier, et al.
Journal of Medicinal Chemistry|June 2, 2021
Structure-Guided Development of Small-Molecule PRC2 Inhibitors Targeting EZH2-EED InteractionDaohai Du, Dandan Xu, Licheng Zhu, et al.
Nature Communications|September 16, 2022
A small molecule antagonist of SMN disrupts the interaction between SMN and RNAP IIYanli Liu, Aman Iqbal, Weiguo Li, et al.
Journal of Medicinal Chemistry|February 1, 2021
Discovery of Small-Molecule Antagonists of the PWWP Domain of NSD2Renato Ferreira de Freitas, Yanli Liu, Magdalena M Szewczyk, et al.
Clinical and Translational Medicine|May 18, 2026
A multi-centre, prospective trial of a methylation-based liquid biopsy for early detection of liver cancer in high-risk populationsRuohan Zhang, Xinrong Yang, Guangming Li, et al.
Pageof 74